Craig B Langman
Overview
Explore the profile of Craig B Langman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langman C, Delos Santos R, Ghossein C, Atherton A, Levtchenko E, Servais A
Kidney Int Rep
. 2024 Feb;
9(2):214-224.
PMID: 38344731
Cystinosis is a rare, inherited, lysosomal storage disorder characterized by the progressive accumulation of intralysosomal cystine and subsequent organ and tissue damage. The kidneys are the first and most severely...
2.
Pagnamenta A, Camps C, Giacopuzzi E, Taylor J, Hashim M, Calpena E, et al.
Genome Med
. 2023 Nov;
15(1):94.
PMID: 37946251
Background: Whole genome sequencing is increasingly being used for the diagnosis of patients with rare diseases. However, the diagnostic yields of many studies, particularly those conducted in a healthcare setting,...
3.
Onder A, Ansari M, Deng F, Grinsell M, Patterson L, Jetton J, et al.
J Clin Med
. 2023 Jul;
12(13).
PMID: 37445286
Our objective was to examine serum ferritin trends after conversion to permanent vascular access (PVA) among children who started hemodialysis (HD) using tunneled cuffed catheters (TCC). Retrospective chart reviews were...
4.
Langman C
Orphanet J Rare Dis
. 2023 Jun;
18(1):162.
PMID: 37353838
The aim of this letter to the editor is to summarize the results from three clinical trial programs evaluating delayed-release cysteamine bitartrate (DR-CYS), which demonstrated the long-term clinical benefits in...
5.
Langman C, Assimos D, Blank M, Calle J, Grauer A, Kausz A, et al.
Clin J Am Soc Nephrol
. 2023 Jun;
18(12):1637-1644.
PMID: 37342976
Enteric hyperoxaluria is a medical condition characterized by elevated urinary oxalate excretion due to increased gastrointestinal oxalate absorption. Causative features include fat malabsorption and/or increased intestinal permeability to oxalate. Enteric...
6.
Carroll A, Tedla Y, Padilla R, Jain A, Segovia E, Moin A, et al.
JAMA Netw Open
. 2023 Apr;
6(4):e237043.
PMID: 37058305
Importance: The 2017 Clinical Practice Guideline (CPG) for the diagnosis and management of pediatric hypertension (PHTN) categorizes a greater proportion of children with elevated blood pressure and PHTN, yet several...
7.
Carroll A, Mohanty N, Wallace A, Langman C, Smith J
Fam Community Health
. 2023 Feb;
46(2):123-127.
PMID: 36799945
The purpose of this study was to contextualize the challenges of diagnosing and managing pediatric hypertension (pHTN) in federally qualified health centers. We conducted a survey among primary care clinicians...
8.
Nester C, Appel G, Bomback A, Bouman K, Cook H, Daina E, et al.
Am J Nephrol
. 2022 Nov;
53(10):687-700.
PMID: 36423588
Introduction: C3 glomerulopathy (C3G) is an ultrarare, chronic and progressive nephropathy mediated by dysregulation of the alternative pathway of complement (AP), with poor prognosis and limited treatment options. Targeted inhibition...
9.
Podos S, Trachtman H, Appel G, Bomback A, Dixon B, Wetzels J, et al.
Am J Nephrol
. 2022 Nov;
53(10):675-686.
PMID: 36404708
Introduction: C3 glomerulopathy (C3G) is a rare, progressive kidney disease resulting from dysregulation of the alternative pathway (AP) of complement. Biomarkers at baseline were investigated in patients with C3G who...
10.
Knapp A, Carroll A, Mohanty N, Fu E, Powell B, Hamilton A, et al.
Implement Sci Commun
. 2022 Mar;
3(1):25.
PMID: 35256017
Background: This article provides a generalizable method, rooted in co-design and stakeholder engagement, to identify, specify, and prioritize implementation strategies. To illustrate this method, we present a case example focused...